40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Analyze analyst forecasts for the company and compare them with competitors.
4.46B
Better than CRK's estimated revenue of 257.41M.
-17.10B
Worse than CRK's estimated ebitda of -1.23B.
-0.91
Better than CRK's estimated eps of -22.56.
-11.92B
Worse than CRK's estimated net income of -1.20B.
1.46B
Better than CRK's estimated ebit of -1.32B.
843.25M
Worse than CRK's estimated sg&a expense of 23.97M.
Analyze DCF forecasts for the company and compare them with competitors.
12.46B
Better than CRK's revenue of 3.63B.
43.96%
Worse than CRK's revenue growth rate of 96.03%.
5.00B
Better than CRK's ebitda of 2.06B.
40.13%
Worse than CRK's ebitda margin of 56.85%.
3.87B
Better than CRK's ebit of 1.57B.
31.06%
Worse than CRK's ebit margin of 43.36%.
1.13B
Worse than CRK's depreciation of 489.45M.
5.00M
Worse than CRK's total cash of 54.65M.
0.04%
Worse than CRK's cash as percentage of revenue of 1.51%.
1.53B
Worse than CRK's receivables of 510.13M.
12.27%
Better than CRK's receivables as percentage of revenue of 14.06%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
436.00M
Better than CRK's accounts payable of 530.20M.
3.50%
Better than CRK's payables as percentage of revenue of 14.61%.
-1.83B
Better than CRK's capital expenditure of -1.07B.
-14.69%
Worse than CRK's capex as percentage of revenue of -29.43%.
12.25%
Worse than CRK's weighted average cost of capital (wacc) of 6.04%.
16.87%
Worse than CRK's cost of equity of 6.67%.
5.31%
Better than CRK's cost of debt of 6.23%.
2.64
Worse than CRK's beta of 0.48.
263.90M
Better than CRK's diluted shares outstanding of 276.81M.
6.68B
Worse than CRK's total debt of 2.71B.
10.03B
Better than CRK's total equity of 4.25B.
16.71B
Better than CRK's total capital of 6.97B.
39.98%
Worse than CRK's debt weighting of 38.96%.
60.02%
Worse than CRK's equity weighting of 61.04%.
3.95B
Better than CRK's ebiat of 1.28B.
3.14B
Better than CRK's unlevered free cash flow of 645.20M.
0.50%
Equal to CRK's long-term growth rate of 0.50%.
-12.22B
Worse than CRK's terminal value of 520.34M.
-10.85B
Worse than CRK's enterprise value of 315.27M.
6.68B
Worse than CRK's net debt of 2.70B.
-17.53B
Worse than CRK's equity value of -2.38B.
-66.42
Worse than CRK's equity value per share of -8.61.
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Analysts expect the stock price to increase by 27.11%.
Buy
Positive consensus among analysts.
